Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin saliva monitoring in neonates
NL-OMON25421Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2018
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of gentamicin in neonatal sepsis, sponsored by Amsterdam University Medical Center. Primary endpoint: Gentamicin concentration in saliva and plasma. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
gentamicin
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NL-OMON25421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25421.